Vidarikand (Pueraria tuberosa): Benefits, Dosage, Safety & Evidence

Questions fréquentes

How does Vidarikand work in the body?

Vidarikand contains isoflavones such as puerarin and daidzein that exhibit phytoestrogenic activity, binding to estrogen receptors and modulating hormonal pathways. These compounds also demonstrate antioxidant and adaptogenic properties. Beta-sitosterol contributes anti-inflammatory effects. The tuber's nutritive compounds support tissue rejuvenation, aligning with its traditional Rasayana classification in Ayurveda for restoring vitality and reproductive health (Evidence Level: C, Traditional).

Does Vidarikand interact with any medications?

Vidarikand may interact with hormone-sensitive medications due to its estrogenic isoflavones. Caution is advised when taking hormonal contraceptives, hormone replacement therapy, or anti-estrogen medications like tamoxifen. It may theoretically enhance estrogenic effects or interfere with hormone-regulating drugs. Patients on diabetes medications should monitor blood sugar levels, as adaptogenic herbs may affect glucose metabolism. Consult a healthcare provider before combining with prescription medications (Evidence Level: C).

What is the recommended dosage for Vidarikand?

The traditional Ayurvedic dosage for Vidarikand root powder is 1-3 grams taken twice daily, typically mixed with warm milk as a carrier to enhance absorption and nutritive benefits. For standardized extracts, 500mg twice daily is commonly recommended. Dosage may vary based on the specific formulation and intended use. Always follow product label instructions or consult a qualified practitioner for personalized dosing guidance (Evidence Level: Traditional).

Is Vidarikand safe during pregnancy and breastfeeding?

Vidarikand is considered unsafe during pregnancy due to its estrogenic compounds, which may stimulate uterine contractions or affect fetal development. However, it has been traditionally used as a galactagogue to promote breast milk production in nursing mothers. Women who are pregnant or planning pregnancy should avoid Vidarikand. Nursing mothers should consult a healthcare provider before use to weigh potential benefits against unknown safety profiles (Evidence Level: C, Traditional).

What are the side effects of Vidarikand?

Vidarikand is generally well-tolerated at recommended doses. Potential side effects include mild gastrointestinal discomfort such as bloating due to its nutritive, heavy properties. The estrogenic isoflavones may cause hormonal effects in sensitive individuals. Those with hormone-sensitive conditions like breast cancer, endometriosis, or uterine fibroids should avoid use due to potential estrogenic stimulation. Discontinue use if adverse reactions occur and consult a healthcare provider (Evidence Level: C, Traditional).

What is Vidarikand used for in Ayurveda?

Vidarikand is classified as a Rasayana (rejuvenating tonic) in Ayurveda, traditionally used to support male and female reproductive health, enhance libido and stamina, and promote overall vitality. It is also used as a galactagogue to increase breast milk production in nursing mothers, and as a nutritive digestive tonic to support weak or debilitated patients. Its adaptogenic properties help the body manage stress and restore energy balance (Evidence Level: Traditional).

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 30 articles PubMed · modèle : gemma4:31b

Résumé

Vidarikand (Pueraria tuberosa) is a perennial herb used in traditional Asian medicine, particularly Ayurveda, for its restorative and therapeutic properties [PMID:24980468, PMID:33708108].

Contexte

Pueraria tuberosa (Willd.) DC, also known as Indian Kudzu, is a perennial herb of the Fabaceae family distributed throughout India and Southeast Asia [PMID:24980468, PMID:33708108].

Usages traditionnels

In Ayurveda, the tuber is used as a restorative tonic, antiaging agent, spermatogenic, and immune booster [PMID:24980468]. It is traditionally recommended for cardiovascular diseases, hepatosplenomegaly, fertility disorders, menopausal syndrome, sexual debility, and spermatorrhoea [PMID:24980468].

Composés actifs

The tuber contains isoflavonoids including puerarin, genistein, daidzein, and tuberosin [PMID:24980468, PMID:33708108]. Other identified constituents include mangiferin, isoorientin, robinin, genistin, daidzin, and various polyphenols, alkaloids, and phytosterols [PMID:28218280, PMID:28243356, PMID:34424815, PMID:36986988].

Mécanisme d'action

Puerarin modulates oxidative stress, apoptosis, cell cycle, and pathways including NF-kB, PI3K/AKT/mTOR, and AMPK to exert anticancer effects [PMID:32021425]. Mangiferin reduces inflammation by inactivating the NLRP3 inflammasome and inhibiting NF-kB translocation [PMID:28218280]. Isoorientin acts as a selective COX-2 inhibitor [PMID:28243356].

Preuves cliniques

Preuve BStage 1 Hypertension

Administration of 3g of P. tuberosa over 12 weeks significantly reduced systolic (25 mmHg), diastolic (11 mmHg), and mean (16 mmHg) blood pressure, while enhancing plasma fibrinolytic activity and total antioxidant status [PMID:24171260]

Preuve DSexual Behavior and Androgenesis

Ethanolic extract in male rats caused a dose-dependent increase in sexual behaviors, increased testis weight, and elevated levels of FSH, LH, and testosterone [PMID:24489512]

Preuve DDiabetes-induced Nephropathy

Extract (PTY-2r) inhibited iNOS and IL-6 by suppressing the PKC-α and NF-kB pathways in rat models [PMID:29770444]

Preuve DOsteoporosis

An ethyl acetate fraction rich in antioxidant compounds alleviated ovariectomized-induced osteoporosis in rats [PMID:33444328]

Preuve DHyperglycemia

Water extract significantly inhibits DPP-IV enzyme, resulting in glucose tolerance response in rats [PMID:29201861]

Sécurité et effets indésirables

Methanolic extract of tubers (PTME) demonstrated hepatotoxicity in rats, with an LD(50) of 227.5 mg/100g BW; repeated doses caused increased hepatic enzymes, hepatocellular necrosis, and oxidative stress [PMID:20122980].

Grossesse et allaitement

Puerarin from P. tuberosa has been analyzed as a promising galactagogue in female rat models [PMID:40162455]. Some extracts have been tested for anti-implantation and abortifacient activity in rodents [PMID:2844661].

Synthèse des preuves

Evidence is primarily based on in vitro studies, animal models (rats/mice/flies), and one small clinical trial (n=30) for hypertension. While promising for metabolic and cardiovascular health, safety concerns regarding hepatotoxicity at high doses in animals have been noted.

Sources PubMed

1.PMID: 24980468 (2014) — Pueraria tuberosa: a review on its phytochemical and therapeutic potential. · Natural product research
2.PMID: 33708108 (2020) — Pueraria tuberosa: A Review on Traditional Uses, Pharmacology, and Phytochemistry. · Frontiers in pharmacology
3.PMID: 32021425 (2020) — Molecular Mechanisms of Anticancer Activities of Puerarin. · Cancer management and research
4.PMID: 25328218 (2014) — Effect of added herb extracts on oxidative stability of ghee (butter oil) during accelerated oxidation condition. · Journal of food science and technology
5.PMID: 40162455 (2024) — In vivo analysis of puerarin from Pueraria tuberosa as a promising galactagogue. · Bioinformation

Vidarikand

Sources et citations

Calculer une dose sûre de Vidarikand